A cluster-randomized trial to reduce caesarean delivery rates in Quebec: cost-effectiveness analysis

Abstract

BackgroundWidespread increases in caesarean section (CS) rates have sparked concerns about risks to mothers and infants and rising healthcare costs. A multicentre, two-arm, cluster-randomized trial in Quebec, Canada assessed whether an audit and feedback intervention targeting health professionals would reduce CS rates for pregnant women compared to usual care, and concluded that it reduced CS rates without adverse effects on maternal or neonatal health. The effect was statistically significant but clinically small. We assessed cost-effectiveness to inform scale-up decisions.MethodsA prospective economic evaluation was undertaken using individual patient data from the Quality of Care, Obstetrics Risk Management, and Mode of Delivery (QUARISMA) trial (April 2008 to October 2011). Analyses took a healthcare payer perspective. The time horizon captured hospital-based costs and clinical events for mothers and neonates from labour onset to 3 months postpartum. Resource use was identified and measured from patient charts and valued using standardized government sources. We estimated the changes in CS rates and costs for the intervention group (versus controls) between the baseline and post-intervention periods. We examined heterogeneity between clinical subgroups of high-risk versus low-risk pregnancies and estimated the joint uncertainty in cost-effectiveness over 20,000 trial simulations. We decomposed costs to identify drivers of change.ResultsThe intervention group experienced per-patient reductions of 0.005 CS (95% confidence interval (CI): −0.015 to 0.004, P = 0.09) and $180 (95% CI: −$277 to − $83, P < 0.001). Women with low-risk pregnancies experienced statistically significant reductions in CS rates and costs; changes for the high-risk subgroup were not significant. The intervention was “dominant” (effective in reducing CS and less costly than usual care) in 86.08% of simulations. It reduced costs in 99.99% of simulations. Cost reductions were driven by lower rates of neonatal complications in the intervention group (−$190, 95% CI: −$255 to − $125, P < 0.001). Given 88,000 annual provincial births, a similar intervention could save $15.8 million (range: $7.3 to $24.4 million) in Quebec annually.ConclusionsFrom a healthcare payer perspective, a multifaceted intervention involving audits and feedback resulted in a small reduction in caesarean deliveries and important cost savings. Cost reductions are consistent with improved quality of care in intervention group hospitals.Trial registrationInternational Clinical Trials Registry Platform, 10.1186/ISRCTN95086407. Registered on 23 October 2007Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-017-0859-8) contains supplementary material, which is available to authorized users.

Diabetic and Elder Patients Experience Superior Cardiovascular Benefits After Gastric Bypass Induced Weight Loss

“…Subjects with diabetes are known for carrying a disproportionately higher risk of CV disease when compared to non-diabetic subjects. In fact, a significant proportion of T2D patients experience clinical remission of the disease after several bariatric surgical interventions, such as RYGB, along with a significant improvement of several independent CV risk factors, including blood glucose levels, blood pressure and lipid profile, which synergistically result in an overall decrease of the estimated CV risk ( 14 ). Moreover, the weight loss profile of patients with T2D diagnosed prior to RYGB surgery was no different from non-diabetic patients, reinforcing the effectiveness of this weight reducing intervention in T2D patients and the likely dissociation of the observed effects in what concerns body weight and CV risk factors.…”

Teaching and performing audits on caesarean delivery reduce the caesarean delivery rate

“…Caesarean delivery rate above the WHO’s upper recommended rate of 15% [ 4 ] has not resulted with an improvement in neonatal outcomes but with an increase in maternal morbidity [ 5 – 7 ]. Indeed, caesarean sections lead to an appreciable increase in maternal complications in the short term (thromboembolism, infection, trauma, bleeding) and long term (risk of ectopic pregnancy, infertility, abnormal placental insertion, risk of uterine rupture) [ 8 , 9 ] and an increase in health costs [ 10 ].…”

A review on cardiovascular outcome studies of dipeptidyl peptidase-4 inhibitors

“…One recent observational study[ 30 ] was conducted to compare a risk of hospitalization for CVDs between gliptins with glimepiride using database of Korean National Health Insurance Service of 19,951 in cohort. This study reported that risk of hospitalization for CVDs was found to be decreased among patients with a history of visit for CVDs in the DPP-4 inhibitors versus glimepiride group.…”